Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher R Flowers

Showing results (61-70 of 430) with videos related to

Pageof 43
Sort By:
Cancer Journal (Sudbury, Mass.)|November 26, 2019
Cost-effectiveness of New Targeted Agents in the Treatment of Chronic Lymphocytic LeukemiaR Andrew Harkins, Sharvil P Patel, Christopher R Flowers
Journal of Oncology Practice|March 9, 2018
Outpatient Management of Fever and Neutropenia in Adults Treated for Malignancy: American Society of Clinical Oncology and Infectious Diseases Society of America Clinical Practice Guideline Update SummaryRandy A Taplitz, Erin B Kennedy, Christopher R Flowers
Bioinformatics (Oxford, England)|July 8, 2022
CondiS web app: imputation of censored lifetimes for machine learning-based survival analysisYizhuo Wang, Christopher R Flowers, Ziyi Li, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|October 19, 2019
Cost burden of diffuse large B-cell lymphomaR Andrew Harkins, Sharvil P Patel, Christopher R Flowers
Journal of Oncology Practice|September 5, 2018
Antimicrobial Prophylaxis for Adult Patients With Cancer-Related Immunosuppression: ASCO and IDSA Clinical Practice Guideline Update SummaryRandy A Taplitz, Erin B Kennedy, Christopher R Flowers
Oncology (Williston Park, N.Y.)|June 27, 2012
Diffuse large B-cell lymphoma: current treatment approachesLoretta J Nastoupil, Adam C Rose, Christopher R Flowers
Expert Opinion on Investigational Drugs|December 13, 2017
Investigational PD-1 inhibitors in HL and NHL and biomarkers for predictors of response and outcomeAndres Chang, Danielle Schlafer, Christopher R Flowers, et al.
Current Problems in Cancer|June 5, 2007
Racial differences in the incidence and outcomes for patients with hematological malignanciesChristopher R Flowers, Roni Glover, Sagar Lonial, et al.
The Annals of Applied Statistics|September 27, 2024
MASH: MEDIATION ANALYSIS OF SURVIVAL OUTCOME AND HIGH-DIMENSIONAL OMICS MEDIATORS WITH APPLICATION TO COMPLEX DISEASESSunyi Chi, Christopher R Flowers, Ziyi Li, et al.
Clinical Lymphoma, Myeloma & Leukemia|December 12, 2018
Intrathecal Central Nervous System Prophylaxis in Patients With Diffuse Large B-cell Lymphoma at an Academic Healthcare SystemKevin H Hall, Kelly Valla, Christopher R Flowers, et al.
Pageof 43

Showing results (61-70 of 430) with videos related to

Sort By:
Pageof 43
Cancer Journal (Sudbury, Mass.)|November 26, 2019
Cost-effectiveness of New Targeted Agents in the Treatment of Chronic Lymphocytic LeukemiaR Andrew Harkins, Sharvil P Patel, Christopher R Flowers
Journal of Oncology Practice|March 9, 2018
Outpatient Management of Fever and Neutropenia in Adults Treated for Malignancy: American Society of Clinical Oncology and Infectious Diseases Society of America Clinical Practice Guideline Update SummaryRandy A Taplitz, Erin B Kennedy, Christopher R Flowers
Bioinformatics (Oxford, England)|July 8, 2022
CondiS web app: imputation of censored lifetimes for machine learning-based survival analysisYizhuo Wang, Christopher R Flowers, Ziyi Li, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|October 19, 2019
Cost burden of diffuse large B-cell lymphomaR Andrew Harkins, Sharvil P Patel, Christopher R Flowers
Journal of Oncology Practice|September 5, 2018
Antimicrobial Prophylaxis for Adult Patients With Cancer-Related Immunosuppression: ASCO and IDSA Clinical Practice Guideline Update SummaryRandy A Taplitz, Erin B Kennedy, Christopher R Flowers
Oncology (Williston Park, N.Y.)|June 27, 2012
Diffuse large B-cell lymphoma: current treatment approachesLoretta J Nastoupil, Adam C Rose, Christopher R Flowers
Expert Opinion on Investigational Drugs|December 13, 2017
Investigational PD-1 inhibitors in HL and NHL and biomarkers for predictors of response and outcomeAndres Chang, Danielle Schlafer, Christopher R Flowers, et al.
Current Problems in Cancer|June 5, 2007
Racial differences in the incidence and outcomes for patients with hematological malignanciesChristopher R Flowers, Roni Glover, Sagar Lonial, et al.
The Annals of Applied Statistics|September 27, 2024
MASH: MEDIATION ANALYSIS OF SURVIVAL OUTCOME AND HIGH-DIMENSIONAL OMICS MEDIATORS WITH APPLICATION TO COMPLEX DISEASESSunyi Chi, Christopher R Flowers, Ziyi Li, et al.
Clinical Lymphoma, Myeloma & Leukemia|December 12, 2018
Intrathecal Central Nervous System Prophylaxis in Patients With Diffuse Large B-cell Lymphoma at an Academic Healthcare SystemKevin H Hall, Kelly Valla, Christopher R Flowers, et al.
Pageof 43